Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis ...Middle East

STOCKHOLM, July 26, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today announced that the Phase 2b TRANSFORM trial met its primary endpoint, showing statistically significant improvement in ALP (Alkaline Phosphatase) for both doses...

Hence then, the article about calliditas announces positive transform phase 2b topline data in primary biliary cholangitis was published today ( Friday 26/07/2024 - 09:24 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitis )

Also on site :

• 75 Amazing Dolly Parton Facts, From Her Childhood to Global Icon
• What To Watch Saturday: Alexander Skarsgård Hosts SNL, WWE Royal Rumble, And More
• These Simulated Diamond Bow Earrings Are Giving Major Coquette Vibes, and They're Now Just $60